Eversept Partners, LP Morphic Holding, Inc. Transaction History

Eversept Partners, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $1.89 Million - $2.87 Million	-43,600 Closed	0 $0
Q3 2021 Nov 08, 2023	BUY	$53.61 - $67.5 $2.34 Million - $2.94 Million	43,600 New	43,600 $2.47 Million
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $2.34 Million - $2.94 Million	43,600 New	43,600 $2.47 Million

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.